351 related articles for article (PubMed ID: 26883396)
41. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome.
Schachar JS; Evans RJ; Parks GE; Zambon J; Badlani G; Walker SJ
Int Urogynecol J; 2019 Nov; 30(11):1863-1870. PubMed ID: 31254048
[TBL] [Abstract][Full Text] [Related]
42. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
Peng CH; Jhang JF; Shie JH; Kuo HC
Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
[TBL] [Abstract][Full Text] [Related]
43. Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis/bladder pain syndrome in a Toll-like receptor-7 agonist-induced experimental animal model in rat.
Tabata H; Sasaki M; Kataoka-Sasaki Y; Shinkai N; Ichihara K; Masumori N; Kocsis JD; Honmou O
BMC Urol; 2021 Nov; 21(1):156. PubMed ID: 34774029
[TBL] [Abstract][Full Text] [Related]
44. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
45. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
[TBL] [Abstract][Full Text] [Related]
46. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
Liu BK; Jin XW; Lu HZ; Zhang X; Zhao ZH; Shao Y
Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
[TBL] [Abstract][Full Text] [Related]
47. Establishment of a Novel Autoimmune Experimental Model of Bladder Pain Syndrome/Interstitial Cystitis in C57BL/6 Mice.
Jin XW; Liu BK; Zhang X; Zhao ZH; Shao Y
Inflammation; 2017 Jun; 40(3):861-870. PubMed ID: 28233078
[TBL] [Abstract][Full Text] [Related]
48.
Li W; Yang F; Zhan H; Liu B; Cai J; Luo Y; Zhou X
Evid Based Complement Alternat Med; 2020; 2020():9026901. PubMed ID: 33133219
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic Effects of AF219 on Interstitial Cystitis/Bladder Pain Syndrome Induced by Cyclophosphamide or Water Avoidance Stress in Rats.
Avci IE; Teke K; Gocmez SS; Kasap M; Akpinar G; Yaprak Bayrak B; Celebi G; Sarihan M; Utkan T; Ozkurkcugil C
Int Urogynecol J; 2024 Mar; 35(3):677-688. PubMed ID: 38376547
[TBL] [Abstract][Full Text] [Related]
50. The study on the function and cell source of interleukin-6 in interstitial cystitis/bladder painful syndrome rat model.
Zheng Z; Zhang J; Zhang C; Li W; Ma K; Huang H; Li K; Yao Y
Immun Inflamm Dis; 2021 Dec; 9(4):1520-1528. PubMed ID: 34407316
[TBL] [Abstract][Full Text] [Related]
51. YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis.
Richter B; Roslind A; Hesse U; Nordling J; Johansen JS; Horn T; Hansen AB
Histopathology; 2010 Sep; 57(3):371-83. PubMed ID: 20840668
[TBL] [Abstract][Full Text] [Related]
52. A genome-scale DNA methylation study in women with interstitial cystitis/bladder pain syndrome.
Bradley MS; Burke EE; Grenier C; Amundsen CL; Murphy SK; Siddiqui NY
Neurourol Urodyn; 2018 Apr; 37(4):1485-1493. PubMed ID: 29363787
[TBL] [Abstract][Full Text] [Related]
53. c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.
de Borst MH; Prakash J; Sandovici M; Klok PA; Hamming I; Kok RJ; Navis G; van Goor H
J Pharmacol Exp Ther; 2009 Dec; 331(3):896-905. PubMed ID: 19717791
[TBL] [Abstract][Full Text] [Related]
54. Caveolin-1 may participate in the pathogenesis of bladder pain syndrome/ interstitial cystitis.
Lin XC; Zhang QH; Zhou P; Zhou ZS; Lu GS
Urol Int; 2011; 86(3):334-9. PubMed ID: 21335944
[TBL] [Abstract][Full Text] [Related]
55. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
[TBL] [Abstract][Full Text] [Related]
56. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
Chuang YC; Chermansky C; Kashyap M; Tyagi P
Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
[TBL] [Abstract][Full Text] [Related]
57. Wnt/β-catenin signaling inhibits oxidative stress-induced ferroptosis to improve interstitial cystitis/bladder pain syndrome by reducing NF-κB.
Fang W; Song X; Li H; Meng F; Lv T; Huang J; Ji X; Lv J; Cai Z; Wang Z
Biochim Biophys Acta Mol Cell Res; 2024 May; ():119766. PubMed ID: 38823528
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis.
Logadottir Y; Fall M; Kåbjörn-Gustafsson C; Peeker R
Scand J Urol Nephrol; 2012 Oct; 46(5):365-70. PubMed ID: 22607036
[TBL] [Abstract][Full Text] [Related]
59. In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis.
Smith N; Saunders D; Lerner M; Zalles M; Mamedova N; Cheong D; Mohammadi E; Yuan T; Luo Y; Hurst RE; Greenwood-Van Meerveld B; Towner RA
PLoS One; 2020; 15(10):e0239282. PubMed ID: 33095778
[TBL] [Abstract][Full Text] [Related]
60. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
